Graph not available
Graph not available

Open Demat Account

50years
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
left-arrow
Fundamentals
Financials
Shareholding
Resistance/Support
Delivery and Volume
About
Management
News
Similar Stocks
right-arrow

Nath Bio-Genes (India) Ltd Performance

Today's Low
190.20
arrowIcon
Today's High
195.65
52 Wk Low
159.00
arrowIcon
52 Wk High
244.60


Open

193.55

Traded Value (Cr)

73.81 L

Prev. Close

193.55

VWAP

196.32

Volume

73,531

Face Value

10

Nath Bio-Genes (India) Ltd Fundamentals

Market Cap
₹ 388 Cr
P/E Ratio (TTM)
10.26
P/B Ratio
0.64
Debt to Equity
0.18
ROE
6.50 %
EPS (TTM)
19.91
Dividend Yield
0.98%
Book Value
317.85

Click here to know more about Fundamentals

Nath Bio-Genes (India) Ltd Financials

Nath Bio-Genes (India) Ltd Financials

Nath Bio-Genes (India) Ltd Shareholding Pattern

Held By Mar 2024 Dec 2023 Sep 2023 Jun 2023
Promoters 45.60 % 45.60 % 45.60 % 45.60 %
Retail 32.25 % 30.95 % 30.50 % 30.37 %
Others 17.52 % 18.77 % 19.31 % 19.35 %
Mutual Funds 4.37 % 4.37 % 4.37 % 4.62 %
FII 0.27 % 0.32 % 0.22 % 0.07 %

Promoters

45.60%

Retail

32.25%

Others

17.52%

Mutual Funds

4.37%

FII

0.27%

Promoters

45.60%

Retail

30.95%

Others

18.77%

Mutual Funds

4.37%

FII

0.32%

Promoters

45.60%

Retail

30.50%

Others

19.31%

Mutual Funds

4.37%

FII

0.22%

Promoters

45.60%

Retail

30.37%

Others

19.35%

Mutual Funds

4.62%

FII

0.07%

Resistance and Support

₹202.67

PIVOT

resistance-arrow
Resistance
First Resistance₹207.033
Second Resistance₹209.717
Third Resistance₹214.083
support-arrow
Support
First Resistance₹199.983
Second Resistance₹195.617
Third Resistance₹192.933
RSI53.452
MACD5.859
ADX31.641
CCI-19.524

Delivery and Volume

PeriodDelivery Volume Traded Volume Delivery Volume %
Day73,53148,77766.34
Week44,80827,66760.17
1 Month47,38928,66162.05
6 Months60,14237,68162.65

About Nath Bio-Genes (India) Ltd

Nath Bio-Genes (India) Limited was incorporated as 'Shivnath Farms Private Limited' on July 14, 1993 as a private limited company under the Companies Act, 1956. The company is engaged in the business of production, processing, and marketing of hybrid and GM seeds. The Company has a product range of field crops, vegetable crops and plant nutrient supplements. The major processing plants are situated at Aurangabad (MS), and Munipalli, Nizamabad (TG). The company has a pan India presence for sales through an extensive network of distributors. In India, the company has nearly 16 business centres covering 131 territories & connecting with over 2,000 distributors, all across the country. The company has been presently venturing to newer geographies outside the country, possessing similar agronomical conditions as India. all set to spread its wings in other parts of Asia, Africa & the Middle East. The company has developed modern infrastructure facilities, biotech lab and seed technology lab. It has a wide dealers and distribution network of PAN India marketing & distribution network which is manned by technically and commercially skilled marketing team. The Company produced several highly ranked cotton seeds in the country which have done well in the ICAR trials and stood the test of time with respect to various virus tolerance as well as improved yield in spite of weather fluctuations. It is the first seed company in Asia Pacific region to get ISO 9001 certificate. It's new launches Sanket and Daksh cotton seeds have been ranked among top 3 in most geographies and under various planting conditions. The consistent high rank achieved by company's new seeds gives reasonable confidence about it growing it's cotton seeds portfolio faster than the industry. The strategy is to provide farmers with a wide range of varieties of cotton seeds suitable for diverse climatic conditions while maintaining yield superiority. The company has worked on de-risking it's business by having multiple growth drivers like paddy, vegetable seeds and plant nutrient in it's portfolio. The company established a network of over 15,000 farmers growing seeds. It has been awarded with the prestigious 'Vasantrao Naik Prathisthan Award' for its contribution for enhancing Agricultural Productivity amongst other rewards & recognition. At present, the company has about 18 breeding and evaluation R&D Stations in different agro-climatic conditions. It has more than 300 acres of land dedicated to research and development, across the nation. It has collaboration with reputed International and National Centres of Excellence (NRCPB, CIMMYT, IRRI, ICRISAT Etc.) The company has a team of handpicked plant breeders and bio technologists, located at key R&D stations, across the country, guided by R&D veterans. It undertakes seed production in over 30,000 acres of land with about 25,000 loyal growers and 72 technically qualified organizers. The company assures that seeds of the highest quality reaches the processing centers by setting rigorous field standards and quality control checks throughout the seed production process. The company has elaborate seed processing facilities with 10 Processing Plants located in Maharashtra and Andhra Pradesh. It has processing arrangements in Gujarat, Karnataka, Tamil Nadu, Madhya Pradesh and Rajasthan on custom basis. The seeds received from growers are processed to achieve quality standards which surpass those prescribed by the regulatory authorities. All the plants are equipped with pre-cleaner, fine cleaner, grader, gravity separator, de-stoner, indented cylinder, treater, needle separator and packing machines which are fully automated. The company has independent facilities for ginning, de-linting, drying, processing, treating, packing and storage of seeds. The seed processing quality is taken to the next level by ensuring improvements in seed viability and prolonging the shelf life of seeds. All the packing material has best environmental barriers characteristics to guarantee optimal storage conditions for the seed. The company's key function is to rigorously test products in various agro-climatic regions and compare the yield to benchmark products of competitors. The product undergoes a rigorous state gate screening process comprising six stages prior to commercial release. Seed Production and Disease Screening are an instrumental part of product development with testing spread across 40 locations, 8 centres and all agro-climatic zones of India. Besides, trials are conducted in three phases to thoroughly test the performance of products before recommending for a national launch. The three different phases of trials are MLT (Multi Location Trial), LST (Large scale Trial) and Demonstrations. For the Multi-level trials, the company have nearly eight stations - each at a different agro-climatic zone divided across the length and breadth of the country.

Managing Director

Satish Kagliwal

Founded

1993

NSE Symbol

NATHBIOGEN

Nath Bio-Genes (India) Ltd Management

NameDesignation
Satish KagliwalManaging Director
Dhiraj RathiCompany Sec. & Compli. Officer
Jeevanlata KagliwalDirector
Ashu JainIndependent Director
Vadla NagbhushanamIndependent Director
Madhukar DeshpandeIndependent Director
HITESH RAJNIKANT PUROHITIndependent Director
Akash Nandkishor KagliwalDirector

Nath Bio-Genes (India) Ltd News

Nath Bio-Genes (India) schedules AGM
On 17 August 2024
Nath Bio-Genes (India) consolidated net profit rises 80.69% in the March 2024 quarter
Sales decline 4.33% to Rs 43.04 crore
Board of Nath Bio-Genes (India) recommends Final Dividend
Of Rs.2 per share
Nath Bio-Genes (India) to announce Quarterly Result
On 8 May 2024
Nath Bio-Genes (India) to convene EGM
On 12 March 2024
Nath Bio-Genes (India) consolidated net profit rises 183.70% in the December 2023 quarter
Sales rise 25.45% to Rs 31.74 crore
Nath Bio-Genes (India) to announce Quarterly Result
On 18 January 2024
Nath Bio-Genes (India) consolidated net profit rises 40.82% in the September 2023 quarter
Sales rise 3.87% to Rs 22.57 crore
Nath Bio-Genes (India) to declare Quarterly Result
On 16 October 2023
Nath Bio-Genes (India) consolidated net profit rises 7.93% in the June 2023 quarter
Sales rise 12.39% to Rs 235.28 crore

Similar Stocks

CompanyMarket CapMarket PriceP/E Ratio
CDSL₹ 21,652 Cr
₹ 2,006.40
(-3.17 %)
59.59
GODREJAGRO₹ 10,665 Cr
₹ 557.80
(0.52 %)
29.87
RTNINDIA₹ 9,682 Cr
₹ 70.50
(0.64 %)
20.25
THOMASCOOK₹ 9,378 Cr
₹ 201.25
(0.98 %)
115.64
CMSINFO₹ 6,495 Cr
₹ 391.65
(-1.87 %)
20.31

Nath Bio-Genes (India) Ltd FAQ

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Nath Bio-Genes (India) Ltd shares in BlinkX

The share price of any stock is volatile and changes during the day due to a variety of variables. Nath Bio-Genes (India) Ltd's share price is ₹192.05 as of May 10, 2024

Nath Bio-Genes (India) Ltd's P/E ratio is 10.26 times as of May 10, 2024.

Nath Bio-Genes (India) Ltd's most recent financial reports indicate a price-to-book ratio of 0.64, showing the company's stock market valuation in relation to the value of its real assets.

Market capitalisation, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Nath Bio-Genes (India) Ltd's market is 388 Cr as on May 10, 2024.

The current financial records of Nath Bio-Genes (India) Ltd show a 6.50% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.

The 52-week high/low price of a Nath Bio-Genes (India) Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Nath Bio-Genes (India) Ltd's 52-week high and low as of May 10, 2024 are ₹195.65 and ₹190.2 respectively.

As of the Mar 2024 quarter, the promoter shareholding in Nath Bio-Genes (India) Ltd stands at 45.60%. During the same period, Institutional Investors have shown a slight decrease in their holdings, dropping from 0.32% to 0.27%.